Brokerages expect Cross Country Healthcare, Inc. (NASDAQ:CCRN) to post sales of $226.29 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for Cross Country Healthcare’s earnings, with the lowest sales estimate coming in at $226.02 million and the highest estimate coming in at $226.56 million. Cross Country Healthcare posted sales of $222.52 million in the same quarter last year, which suggests a positive year over year growth rate of 1.7%. The firm is scheduled to announce its next earnings results on Wednesday, March 7th.

On average, analysts expect that Cross Country Healthcare will report full year sales of $226.29 million for the current financial year, with estimates ranging from $871.39 million to $871.94 million. For the next financial year, analysts anticipate that the firm will post sales of $940.37 million per share, with estimates ranging from $940.11 million to $940.64 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Cross Country Healthcare.

Cross Country Healthcare (NASDAQ:CCRN) last announced its quarterly earnings results on Wednesday, November 1st. The business services provider reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.05. The company had revenue of $228.50 million for the quarter, compared to analyst estimates of $228.97 million. Cross Country Healthcare had a net margin of 0.19% and a return on equity of 11.69%. The firm’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.24 EPS.

A number of research firms have weighed in on CCRN. Zacks Investment Research lowered shares of Cross Country Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. TheStreet raised shares of Cross Country Healthcare from a “c+” rating to a “b” rating in a report on Wednesday, September 27th. Cantor Fitzgerald reissued a “buy” rating and set a $18.00 target price on shares of Cross Country Healthcare in a report on Wednesday, November 1st. Benchmark reissued a “buy” rating and set a $17.00 target price (down from $18.00) on shares of Cross Country Healthcare in a report on Wednesday, August 9th. Finally, BMO Capital Markets reduced their target price on shares of Cross Country Healthcare from $15.00 to $14.00 and set an “outperform” rating on the stock in a report on Monday, November 6th. Two analysts have rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the stock. Cross Country Healthcare currently has an average rating of “Hold” and an average price target of $15.31.

Shares of Cross Country Healthcare (NASDAQ CCRN) opened at $13.44 on Wednesday. The stock has a market cap of $485.20, a P/E ratio of 20.78, a P/E/G ratio of 1.18 and a beta of 0.73. The company has a current ratio of 2.14, a quick ratio of 2.14 and a debt-to-equity ratio of 0.46. Cross Country Healthcare has a 1-year low of $11.07 and a 1-year high of $16.38.

In other news, Director Thomas C. Dircks purchased 10,000 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were purchased at an average price of $11.77 per share, for a total transaction of $117,700.00. Following the transaction, the director now owns 104,571 shares of the company’s stock, valued at $1,230,800.67. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 3.90% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. JPMorgan Chase & Co. lifted its position in shares of Cross Country Healthcare by 7.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,000,840 shares of the business services provider’s stock worth $28,331,000 after purchasing an additional 133,341 shares during the period. Vanguard Group Inc. lifted its position in shares of Cross Country Healthcare by 4.7% in the 2nd quarter. Vanguard Group Inc. now owns 1,919,676 shares of the business services provider’s stock worth $24,783,000 after purchasing an additional 86,718 shares during the period. Benefit Street Partners LLC lifted its position in shares of Cross Country Healthcare by 30.9% in the 2nd quarter. Benefit Street Partners LLC now owns 1,544,440 shares of the business services provider’s stock worth $19,939,000 after purchasing an additional 364,229 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Cross Country Healthcare by 12.9% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,448,727 shares of the business services provider’s stock worth $20,615,000 after purchasing an additional 165,624 shares during the period. Finally, Simcoe Capital Management LLC lifted its position in shares of Cross Country Healthcare by 120.9% in the 2nd quarter. Simcoe Capital Management LLC now owns 1,227,590 shares of the business services provider’s stock worth $15,848,000 after purchasing an additional 671,885 shares during the period. Hedge funds and other institutional investors own 92.13% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/12/06/226-29-million-in-sales-expected-for-cross-country-healthcare-inc-ccrn-this-quarter-2.html.

About Cross Country Healthcare

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Get a free copy of the Zacks research report on Cross Country Healthcare (CCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.